| Ident. | Authors (with country if any) | Title |
|---|
| 000136 (2021) |
T Y Andy Ko [Malaisie] ; L S Chen [Malaisie] ; I X Pang [Malaisie] ; H S Ling [Malaisie] ; T C Wong [Malaisie] ; L L Sia Tonnii [Malaisie] ; K T Koh [Malaisie] | Smartphone electrocardiogram for QT interval monitoring in Coronavirus Disease 2019 (COVID-19) patients treated with Hydroxychloroquine. |
| 000236 (2021) |
Hui Moon Koh [Malaisie] ; Pei Feng Chong [Malaisie] ; Ju Nee Tan [Malaisie] ; Suresh Kumar Chidambaram [Malaisie] ; Hiu Jian Chua [Malaisie] | QT prolongation associated with hydroxychloroquine and protease inhibitors in COVID-19. |
| 000247 (2021) |
Zaki Akhtar [Royaume-Uni] ; Mark M. Gallagher [Royaume-Uni] ; Yee Guan Yap [Malaisie] ; Lisa W M. Leung [Royaume-Uni] ; Ahmed I. Elbatran [Royaume-Uni] ; Brendan Madden [Royaume-Uni] ; Victoria Ewasiuk [Royaume-Uni] ; Louise Gregory [Royaume-Uni] ; Aodhan Breathnach [Royaume-Uni] ; Zhong Chen [Royaume-Uni] ; David S. Fluck [Royaume-Uni] ; Sumeet Sharma [Royaume-Uni] | Prolonged QT predicts prognosis in COVID-19. |
| 000551 (2021) |
Muhammad Taher [Malaisie] ; Noratika Tik [Malaisie] ; Deny Susanti [Malaisie] | Drugs intervention study in COVID-19 management. |
| 000606 (2021) |
Chia Siang Kow [Malaisie] ; Syed Shahzad Hasan [Royaume-Uni, Australie] | Colchicine as an adjunct to heparin for prophylaxis of venous thromboembolism in patients with COVID-19. |
| 000715 (2021) |
Chia Siang Kow [Malaisie] ; Syed Shahzad Hasan [Australie] | Azithromycin in patients with COVID-19: Friend or foe? |
| 000804 (2020) |
Md Insiat Islam Rabby [Malaisie] ; Farzad Hossain [Bangladesh] | Study of ongoing registered clinical trials on COVID-19: a narrative review. |
| 000963 (2020) |
V. Ramachandran [Malaisie] ; R R Marimuthu [Inde] ; R S Chinnambedu [Inde] | World War against COVID-19: How strong is our armamentarium? |
| 000983 (2020) |
Mohammed H. Shalayel [Arabie saoudite] ; Ghassab M. Al-Mazaideh [Arabie saoudite] ; Saleem H. Aladaileh [Arabie saoudite] ; Farhan K. Al-Swailmi [Arabie saoudite] ; Mohammad G. Al-Thiabat [Malaisie] | Vitamin D is a potential inhibitor of COVID-19: In silico molecular docking to the binding site of SARS-CoV-2 endoribonuclease Nsp15. |
| 000A04 (2020) |
Faizan Mazhar [Italie] ; Muhammad Abdul Hadi [Royaume-Uni] ; Chia Siang Kow [Malaisie] ; Albaraa Mohammed N. Marran [Arabie saoudite] ; Hamid A. Merchant [Royaume-Uni] ; Syed Shahzad Hasan [Royaume-Uni] | Use of hydroxychloroquine and chloroquine in COVID-19: How good is the quality of randomized controlled trials? |
| 000B78 (2020) |
Abdullahi Rabiu Abubakar [Nigeria] ; Ibrahim Haruna Sani [Nigeria] ; Brian Godman [Royaume-Uni] ; Santosh Kumar [Inde] ; Salequl Islam [Bangladesh] ; Iffat Jahan [Bangladesh] ; Mainul Haque [Malaisie] | Systematic Review on the Therapeutic Options for COVID-19: Clinical Evidence of Drug Efficacy and Implications. |
| 000D70 (2020) |
Israel Abebrese Sefah [Ghana] ; Olayinka O. Ogunleye [Nigeria] ; Darius Obeng Essah [Ghana] ; Sylvia A. Opanga [Kenya] ; Nadia Butt [Kenya] ; Annie Wamaitha [Kenya] ; Anastasia Nkatha Guantai [Kenya] ; Ibrahim Chikowe [Malawi] ; Felix Khuluza [Malawi] ; Dan Kibuule [Namibie] ; Lahya Nambahu [Namibie] ; Abdullahi Rabiu Abubakar [Nigeria] ; Ibrahim Haruna Sani [Nigeria] ; Zikria Saleem [Pakistan] ; Aubrey C. Kalungia [Zambie] ; Thuy Nguyen Thi Phuong [Viêt Nam] ; Mainul Haque [Malaisie] ; Salequl Islam [Bangladesh] ; Santosh Kumar [Inde] ; Jacqueline Sneddon [Royaume-Uni] ; Joshua Wamboga [Ouganda] ; Janney Wale [Australie] ; Nenad Miljkovi [Serbie] ; Amanj Kurdi [Royaume-Uni, Iraq] ; Antony P. Martin [Royaume-Uni] ; Brian Godman [Royaume-Uni, Afrique du Sud, Malaisie, Suède] | Rapid Assessment of the Potential Paucity and Price Increases for Suggested Medicines and Protection Equipment for COVID-19 Across Developing Countries With a Particular Focus on Africa and the Implications. |
| 000D71 (2020) |
Brian Godman [Royaume-Uni, Suède, Afrique du Sud, Malaisie] ; Mainul Haque [Malaisie] ; Salequl Islam [Bangladesh] ; Samiul Iqbal [Bangladesh] ; Umme Laila Urmi [Bangladesh] ; Zubair Mahmood Kamal [États-Unis] ; Shahriar Ahmed Shuvo [Bangladesh] ; Aminur Rahman [Bangladesh] ; Mustafa Kamal [Bangladesh] ; Monami Haque [Bangladesh] ; Iffat Jahan [Bangladesh] ; Md Zakirul Islam [Bangladesh] ; Mohammad Monir Hossain [Bangladesh] ; Munzur-E-Murshid [Bangladesh] ; Santosh Kumar [Inde] ; Jaykaran Charan [Inde] ; Rohan Bhatt [Inde] ; Siddhartha Dutta [Inde] ; Jha Pallavi Abhayanand [Inde] ; Yesh Sharma [Inde] ; Zikria Saleem [Pakistan] ; Thuy Nguyen Thi Phuong [Viêt Nam] ; Hye-Young Kwon [Royaume-Uni, Corée du Sud] ; Amanj Kurdi [Royaume-Uni, Iraq] ; Janney Wale [Australie] ; Israel Sefah [Ghana] | Rapid Assessment of Price Instability and Paucity of Medicines and Protection for COVID-19 Across Asia: Findings and Public Health Implications for the Future. |
| 000E59 (2020) |
Chia Siang Kow [Malaisie] ; Syed Shahzad Hasan [Royaume-Uni] | Pharmacotherapeutic considerations for systemic rheumatic diseases amid the COVID-19 pandemic: more questions than answers. |
| 000E60 (2020) |
Woon Yi Law [Malaisie] ; Mohd Razip Asaruddin [Malaisie] ; Showkat Ahamd Bhawani [Malaisie] ; Samsur Mohamad [Malaisie] | Pharmacophore modelling of vanillin derivatives, favipiravir, chloroquine, hydroxychloroquine, monolaurin and tetrodotoxin as MPro inhibitors of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). |
| 001032 (2020) |
Mohammed Noor Embi [Malaisie] ; Nagesswary Ganesan [Malaisie] ; Hasidah Mohd Sidek [Malaisie] | Is GSK3β a molecular target of chloroquine treatment against COVID-19? |
| 001313 (2020) |
Chee Peng Hor [Malaisie] ; Narwani Hussin [Malaisie] ; Saravanaa Nalliah [Malaisie] ; Way Ti Ooi [Malaisie] ; Xing Yi Tang [Malaisie] ; Sara Zachariah [Malaisie] ; Gurpreet Pal Singh Jugindar Singh [Malaisie] ; Rosilawati Abdul Rani [Malaisie] ; Kunaraj Perumal [Malaisie] ; Wee Kooi Cheah [Malaisie] | Experience of short-term hydroxychloroquine and azithromycin in COVID-19 patients and effect on QTc trend. |
| 001400 (2020) |
Zheng Yao Low [Malaisie] ; Isra Ahmad Farouk [Malaisie] ; Sunil Kumar Lal [Malaisie] | Drug Repositioning: New Approaches and Future Prospects for Life-Debilitating Diseases and the COVID-19 Pandemic Outbreak. |
| 001787 (2020) |
Muhammad Asif [Pakistan] ; Mohammad Saleem [Pakistan] ; Malik Saadullah [Pakistan] ; Hafiza Sidra Yaseen [Pakistan] ; Raghdaa Al Zarzour [Malaisie] | COVID-19 and therapy with essential oils having antiviral, anti-inflammatory, and immunomodulatory properties. |
| 001809 (2020) |
Cheng Lay Teh [Oman] ; Yaw Kiet Cheong [Malaisie] ; Wan Rosmaiza Wan Musa [Malaisie] ; Sharifah Aishah Wan Mohd Akbar [Malaisie] ; Noraini Mat Husin [Malaisie] ; Suk Chyn Gun [Malaisie] | COVID-19 among Malaysian patients with systemic lupus erythematosus on hydroxychloroquine. |
| 001858 (2020) |
Jeyasakthy Saniasiaya [Malaisie] ; Jeyanthi Kulasegarah [Malaisie] | Auditory Cinchonism in COVID Era. |
